期刊文献+

急性心肌梗死患者C反应蛋白浓度变化与梗死面积的相关性研究

下载PDF
导出
作者 房艳红
出处 《临床荟萃》 CAS 2010年第10期879-881,共3页 Clinical Focus
  • 相关文献

参考文献9

  • 1Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR) :Consensus Panel report[J]. Eur Heart J,2004,25(21) : 1940-1965.
  • 2Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart[J]. Circulation,2002,105(4): 539-542.
  • 3Armani A, Becher RC. The biology, utilization,and attenuation of C reactive protein in cardiovascular disease: Part Ⅰ[J]. Am Heart J,2005,149(6):971-976.
  • 4严江涛,汪道文.C反应蛋白和心血管疾病[J].临床内科杂志,2009,26(1):5-7. 被引量:19
  • 5Wagner A, Mahrholdt H, Holly TA, et ah Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection for detection of subendocardial myocardial infarcts; an imaging study [J]. Lancet,2003,361(9355) :374-379.
  • 6Baks T,Cademartiri F, Moelker AD, et al. Multislice computed tomography and magnetic resonance imaging for the assessment of reperfused acute myocardial infarction[J]. J Am Coll Cardiol, 2006,48(48) :144-152.
  • 7Hsu LY, Natanzon A, Kellman P, et al. Quantitative myocardial infarction on delayed enhancement MRI. Part Ⅰ: animal validation of an automated feature analysis and combined thresh olding infarct sizing algorithn[J]. J Magn Reson Imaging,2006, 23(3) ,298-308.
  • 8Saeed M, Lee R J, Weber O, et al. Scarred myocardium imposes additional burden on remote viable myoeardium despite a reduction in the extent of area with late contrast MR enhancement[J]. Eur Radiol,2006,16(4) :827-836.
  • 9Yan AT,Shayne AJ,Brown KA,et al. Characterization of the peri infarct zone by contrast enhanced cardiac magnetic resonance imaging is a powerful predictor of post myocardial infarction mortality[J]. Circulation, 2006,114 (1):32-39.

二级参考文献25

  • 1Armani A, Becher RC. The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: Part I. Am Heart J ,2005,149: 971-976.
  • 2Devaraj S, Venugopal S, Jialal I. Native pentameric C-reactive protein displays more potent pro-atherogenie activities in human aortic endothelial cells than modified C-reactive protein. Atherosclerosis, 2005,184: 48-52.
  • 3Devaraj S,Du Clos TW ,Jialal I. Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol, 2005,26 : 1359-1363.
  • 4Qamirani E, Ren Y, Kuo L, et al. C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD (P) H oxidase. Arterioscler Thromb Vasc Biol, 2005,25:995-1001.
  • 5Kibayashi E, Urakazal M,Kobashi C, et al. Inhibitory effect of pitavastatin (NK-104) on the C-reactive protein-induced interleukin-8 production in human aortic endothelial cell. Clin Sci (Lond) ,2005,108:515-521.
  • 6Verma S, Badiwala MV, Weisel RD, et al. C-reactive protein upregulates the NF-κB signaling pathway in saphenous vein endothelial cells:implications for atherosclerosis and restenosis. J Thorac Cardiovasc Surg, 2003,126:1886-1891.
  • 7Verma S, Wang CH, Li SH, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation ,2002,106:913-919.
  • 8Venugopal SK, Devaraj S, Jialal I, et al. C-reactive protein decreases prostacyclin release from human aortic endothelial cells. Circulation, 2003,108 : 1676-1678.
  • 9Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation ,2002,105 : 1890-1896.
  • 10Wang CH,Li SH ,Weisel RD, et al. C-reactive protein upgratulates angiotensin type I receptors in vascular smooth muscle. Circulation ,2003, 107 : 1783-1790.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部